<?xml version="1.0" encoding="UTF-8"?>
<p>The seroprevalence of anti-HEV among blood donors in northern California is 1.2–1.4%. The data is consistent with that from prior seroprevalence studies (1–5%) among blood donors in the United States [
 <xref rid="B86-medicina-56-00206" ref-type="bibr">86</xref>]. Seroprevalence studies from eight US states indicate that 18% and 17% of normal blood donor samples were anti-HEV positive when tested with human HEV antigen and swine HEV antigen, respectively. Despite the low numbers reported, it must be remembered that most infections are “missed” due to lack of FDA-approved human diagnostic assays [
 <xref rid="B49-medicina-56-00206" ref-type="bibr">49</xref>].
</p>
